Peter the Bridge, Saint Petersburg, Russia

EFFERVESCENCE 2019: NEOMED Institute will co-host a conference on SMEs financing

April 8th, 2019 |Announcement| No Comments

Montreal, Quebec, Canada, April 8th 2019– As part of this unique event, developed by a collective of 14 lead organizations in the LSHT (Life Sciences and Health Technologies) sector in Quebec, the NEOMED Institute will present the theme “Public-Private Collaborations: leverage for financing?” with the participation of the AmorChem II venture capital fund. The two groups invited some entrepreneurs to share their solutions to handling these financial issues.

During this session, moderated by Roberto Bellini, President and CEO of Bellus Health, you will discover the experience and financial challenges that have been faced:

  • Pascal Neuville, CEO of Domain Therapeutics
  • Frederic Leduc, President & CEO of Immune Biosolutions
  • Sarah Jenna, Co-founder & CEO of My Intelligent Machines
  • Etienne Lagacé, Co-founder & CEO of Moonshot Health
  • Sean McDonald, President & CEO of Corbin Therapeutics
  • Francois Ravenelle, Founder & CEO of Inversago

There is still time to register!

EFFERVESCENCE 2019 will be held on April 24 and 25 at La TOHU (Montreal).

Consult the full EFFERVESCENCE program 

 

For more information, please contact:

Shirley Robinet
Communications Coordinator, NEOMED Institute 
srobinet@neomed.ca
(514) 375-3334 ext. 111

Share this

Leave a Reply

Similar News

image articles
7 December 2018

Support for the NEOMED Institute for the implementation of an innovation and commercialization complex

Read complete news
image articles
14 November 2018

NEOMED Institute Announces the Appointment of Dr. Youssef Bennani to its Board of Directors

Read complete news
© 2019 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia